R-Tech Ueno is a venture corporation specializing in the research, development, manufacturing and marketing of innovative pharmaceutical products. Our three main businesses are:

  1. Research and development of new prescription drugs for ophthalmic diseases
  2. Manufacturing and marketing Rescula® Eye Drops, glaucoma and ocular hypertension drug
  3. Support service for pharmaceutical R&D that corresponds globally

R-Tech Ueno contributes to the progress of medicine and the society by efficienlty developing effective pharmaceutical products derived from our own innovative ideas.

 


Jun 4, 2008
Recombinant human serum albumin Licence agreement for the development and commercialization of an ophthalmic solution for use in the treatment of dry eye

Apr 30, 2008
R-Tech Ueno Expands AMITIZAˇ¦Production Facilities
PDF

Jun 28, 2007
R-Tech Ueno Appointed New Corporate Auditor